Literature DB >> 9669921

Treatment of postmenopausal osteoporosis.

M Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9669921

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Amorphigenin inhibits Osteoclast differentiation by suppressing c-Fos and nuclear factor of activated T cells.

Authors:  Bong Gyu Kim; Han Bok Kwak; Eun-Yong Choi; Hun Soo Kim; Myung Hee Kim; Seong Hwan Kim; Min-Kyu Choi; Churl Hong Chun; Jaemin Oh; Jeong-Joong Kim
Journal:  Anat Cell Biol       Date:  2010-12-31

2.  The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation.

Authors:  Fei-Lan Liu; Chun-Liang Chen; Chia-Chung Lee; Cheng-Chi Wu; Teng-Hsu Hsu; Chang-Youh Tsai; Hsu-Shan Huang; Deh-Ming Chang
Journal:  Int J Med Sci       Date:  2017-07-19       Impact factor: 3.738

3.  Similarities and differences between bone quality parameters, trabecular bone score and femur geometry.

Authors:  Kyong Young Kim; Kyoung Min Kim
Journal:  PLoS One       Date:  2022-01-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.